Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
HK Stock MarketDetailed Quotes
NT PHARMA (01011)
- 0.680
- 0.0000.00%
Market Closed May 6 09:00 CST
645.32MMarket Cap-22.67P/E (TTM)
0.000High0.000Low2.00KVolume0.680Open0.680Prev Close1.24KTurnover0.00%Turnover RatioLossP/E (Static)949.00MShares1.35052wk High-2.13P/B645.32MFloat Cap0.36052wk Low--Dividend TTM949.00MShs Float42.200Historical High--Dividend LFY0.00%Range %0.170Historical Low0.620Avg Price10000Lot Size--Div Yield TTM--Div Yield LFY
NT PHARMA (01011) Cash Flow
All
YOY
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 50.91%-26.26M | ---- | 57.76%-53.48M | ---- | -133.18%-126.61M | ---- | 63.50%-54.3M | ---- | 59.68%-148.75M | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 36.36%-7K | ---- | 21.43%-11K | ---- | 41.67%-14K | ---- | 89.96%-24K | ---- | 91.57%-239K | ---- |
| Attributable subsidiary (profit) loss | ---- | ---- | 72.34%-10.24M | ---- | -311.41%-37.04M | ---- | 73.90%-9M | ---- | -431,025.00%-34.49M | ---- |
| Impairment and provisions: | ---- | ---- | 50.63%6.3M | ---- | -82.93%4.18M | ---- | -53.84%24.48M | ---- | -50.80%53.04M | ---- |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | -82.05%14K | ---- | --78K | ---- | ---- | ---- |
| -Impairmen of inventory (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | 257.45%1.68M | ---- | 19.90%470K | ---- |
| -Impairment of trade receivables (reversal) | ---- | ---- | ---- | ---- | -64.00%4.17M | ---- | -25.58%11.57M | ---- | 145.86%15.55M | ---- |
| -Other impairments and provisions | ---- | ---- | --6.3M | ---- | ---- | ---- | -69.87%11.16M | ---- | -66.96%37.02M | ---- |
| Revaluation surplus: | -337.69%-14.08M | ---- | 388.32%5.92M | ---- | 64.25%-2.05M | ---- | -178.34%-5.75M | ---- | -34.89%7.34M | ---- |
| -Other fair value changes | -337.69%-14.08M | ---- | 388.32%5.92M | ---- | 64.25%-2.05M | ---- | -178.34%-5.75M | ---- | -34.89%7.34M | ---- |
| Asset sale loss (gain): | ---- | ---- | ---- | ---- | -2,063.42%-12.29M | ---- | 101.27%626K | ---- | -250.48%-49.47M | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | -2,060.38%-12.27M | ---- | 101.60%626K | ---- | -219.31%-39.03M | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---19K | ---- | ---- | ---- | 1,335.00%2.3M | ---- |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---12.73M | ---- |
| Depreciation and amortization: | -2.42%644K | ---- | -88.78%660K | ---- | -72.09%5.88M | ---- | -50.13%21.07M | ---- | 73.17%42.25M | ---- |
| -Amortization of intangible assets | ---- | ---- | ---- | ---- | -44.06%1.1M | ---- | -0.10%1.97M | ---- | -3.57%1.97M | ---- |
| Financial expense | -11.74%27.84M | ---- | -38.18%31.54M | ---- | -28.87%51.03M | ---- | -19.15%71.73M | ---- | 2.53%88.73M | ---- |
| Special items | -98.04%139K | ---- | -91.81%7.1M | ---- | 14,477.82%86.74M | ---- | 287.70%595K | ---- | 11.45%-317K | ---- |
| Operating profit before the change of operating capital | 4.08%-11.72M | ---- | 59.54%-12.21M | ---- | -161.05%-30.18M | ---- | 217.94%49.44M | ---- | 61.64%-41.92M | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -38.69%-233K | ---- | 93.35%-168K | ---- | -112.71%-2.53M | ---- | 483.27%19.88M | ---- | -176.50%-5.19M | ---- |
| Accounts receivable (increase)decrease | -28.49%-1.28M | ---- | -101.48%-997K | ---- | 309.70%67.33M | ---- | -504.32%-32.11M | ---- | -70.08%7.94M | ---- |
| Accounts payable increase (decrease) | 81.82%7.84M | ---- | -74.20%4.31M | ---- | 1,722.91%16.72M | ---- | 98.91%-1.03M | ---- | -192.86%-94.81M | ---- |
| Special items for working capital changes | ---- | ---- | ---- | ---- | ---- | ---- | 290.00%1.06M | ---- | ---560K | ---- |
| Cash from business operations | 40.56%-5.39M | ---- | -117.66%-9.07M | ---- | 37.81%51.33M | ---- | 127.69%37.25M | ---- | -614.41%-134.54M | ---- |
| Other taxs | ---- | ---- | ---- | ---- | 17.60%-857K | ---- | -30.65%-1.04M | ---- | ---796K | ---- |
| Special items of business | ---- | -235.06%-19.24M | ---- | -148.66%-5.74M | ---- | -52.57%11.8M | ---- | -23.48%24.87M | ---- | 15.51%32.5M |
| Net cash from operations | 40.56%-5.39M | -235.06%-19.24M | -117.96%-9.07M | -148.66%-5.74M | 39.40%50.48M | -52.57%11.8M | 126.76%36.21M | -23.48%24.87M | -616.47%-135.34M | 15.51%32.5M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -36.36%7K | ---- | -21.43%11K | ---- | -41.67%14K | ---- | -89.96%24K | ---- | -91.57%239K | ---- |
| Decrease in deposits (increase) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -56.94%25.52M | ---- |
| Sale of fixed assets | ---- | ---- | ---- | ---- | --159K | ---- | ---- | ---- | --3.56M | ---- |
| Purchase of fixed assets | 10.67%-159K | ---- | 98.34%-178K | ---- | -138.83%-10.73M | ---- | -595.67%-4.49M | ---- | 97.29%-646K | ---- |
| Selling intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --29M | ---- |
| Purchase of intangible assets | ---- | ---- | ---- | ---- | ---2.16M | ---- | ---- | ---- | ---- | ---- |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | -102.19%-197K | ---- | -98.41%9M | ---- | 1.39%566.12M | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -35,368.51%-364.97M | ---- |
| Other items in the investment business | ---- | 103.88%5K | 99.76%-22K | 93.28%-129K | ---9.22M | 7.74%-1.92M | ---- | -102.00%-2.08M | ---1M | 172.84%104.3M |
| Net cash from investment operations | 19.58%-152K | 103.88%5K | 99.15%-189K | 93.28%-129K | -588.74%-22.14M | 7.74%-1.92M | -98.24%4.53M | -102.00%-2.08M | -56.71%257.81M | 172.84%104.3M |
| Net cash before financing | 40.13%-5.54M | -227.61%-19.23M | -132.66%-9.26M | -159.43%-5.87M | -30.45%28.34M | -56.66%9.88M | -66.74%40.74M | -83.34%22.79M | -80.30%122.48M | 106.14%136.8M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 31.93%34.37M | ---- | 75.31%26.05M | ---- | -49.70%14.86M | ---- | -59.68%29.54M | ---- | -93.72%73.27M | ---- |
| Refund | -273.71%-7.18M | ---- | 77.59%-1.92M | ---- | 88.14%-8.57M | ---- | 51.85%-72.28M | ---- | 91.31%-150.13M | ---- |
| Issuing shares | ---- | ---- | ---- | ---- | 364.77%9.39M | ---- | --2.02M | ---- | ---- | ---- |
| Issuance of bonds | ---- | ---- | 43.44%4.62M | ---- | -86.50%3.22M | ---- | 139.65%23.84M | ---- | -29.88%9.95M | ---- |
| Interest paid - financing | -99.17%-19.89M | ---- | 46.81%-9.99M | ---- | -6.84%-18.77M | ---- | 59.01%-17.57M | ---- | 34.44%-42.86M | ---- |
| Issuance expenses and redemption of securities expenses | 66.05%-1.83M | ---- | 80.88%-5.38M | ---- | -172.63%-28.15M | ---- | 17.99%-10.33M | ---- | -22.76%-12.59M | ---- |
| Other items of the financing business | ---- | 242.66%14.64M | ---- | 150.88%4.27M | ---- | 68.41%-8.4M | ---- | 81.65%-26.59M | ---- | -94.15%-144.9M |
| Net cash from financing operations | -61.50%4.87M | 242.66%14.64M | 143.67%12.65M | 150.88%4.27M | 37.93%-28.97M | 68.41%-8.4M | 62.60%-46.68M | 81.65%-26.59M | 80.01%-124.8M | -94.15%-144.9M |
| Effect of rate | -136.81%-1.73M | -106.82%-400K | 1,860.42%4.71M | 26.22%5.87M | -93.12%240K | -58.87%4.65M | 3.62%3.49M | 89.06%11.3M | 118.78%3.37M | -55.00%5.98M |
| Net Cash | -119.72%-670K | -187.35%-4.59M | 634.28%3.4M | -208.05%-1.6M | 89.29%-636K | 138.88%1.48M | -155.97%-5.94M | 53.10%-3.8M | 4.92%-2.32M | 2.01%-8.1M |
| Begining period cash | 533.09%9.62M | 533.09%9.62M | -20.67%1.52M | -74.37%1.52M | -56.10%1.92M | -37.19%5.93M | 31.56%4.36M | 22.73%9.44M | -88.24%3.32M | -72.71%7.69M |
| Cash at the end | -24.96%7.22M | -20.17%4.62M | 533.09%9.62M | -51.97%5.79M | -20.67%1.52M | -28.84%12.06M | -56.10%1.92M | 204.29%16.95M | -44.31%4.36M | -83.23%5.57M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"